Adherence to Capecitabine Treatment and Contributing Factors among Cancer Patients in Malaysia

Zahrina, Abdul Kadir; Norsa'adah, Bachok; Hassan, Norul Badriah; Norazwany, Yaacob; Norhayati, Md Isa; Roslan, Mohd Haron; Wan Nazuha, Wan Rusik

추천

검색

자료유형: 학술저널

저자정보: Zahrina, Abdul Kadir (Unit of Biostatistics and Research Methodology, School of Medical Sciences, Universiti Sains Malaysia) Norsa'adah, Bachok (Unit of Biostatistics and Research Methodology, School of Medical Sciences, Universiti Sains Malaysia) Hassan, Norul Badriah (Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia) Norazwany, Yaacob (Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia) Norhayati, Md Isa (Department Pharmacy, Hospital Sultan Ismail) Roslan, Mohd Haron (Department Oncology and Radiotherapy, Hospital Sultan Ismail) Wan Nazuha, Wan Rusik (Oncology and Radiotherapy Institute, Hospital Kuala Lumpur)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제21호

발행연도: 2014.1

수록면: 9,225 - 9,232 (8page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Ensuring adherence to chemotherapy is important to prevent disease progression, prolong survival and sustain good quality of life. Capecitabine is a complex chemotherapeutic agent with many side effects that might affect patient adherence to treatment. This cross sectional study aimed to determine adherence to capecitabine and its contributing factors among cancer outpatients in Malaysia. One hundred and thirteen patients on single regime capecitabine were recruited from Hospital Sultan Ismail and Hospital Kuala Lumpur from October 2013 to March 2014. Adherence was determined based on adherence score using validated Medication Compliance Questionnaire. Patient socio-demographics, disease, and treatment characteristics were obtained from medical records. Satisfaction score was measured using the validated Patient Satisfaction with Healthcare questionnaire. The mean adherence score was 96.1% (standard deviation: 3.29%). The significant contributing factors of adherence to capecitabine were Malay ethnicity [${\beta}=1.3$; 95% confidence interval (CI): 0.21, 2.43; p value=0.020], being female [${\beta}=1.8$; 95%CI: 0.61, 2.99; p value=0.003]), satisfaction score [${\beta}=0.08$; 95%CI: 0.06, 1.46; p value=0.035], presence of nausea or vomiting [${\beta}=2.3$; 95%CI: 1.12, 3.48; p value <0.001] and other side effects [${\beta}=1.45$; 95%CI: 0.24, 2.65; p value=0.019]. Adherence to capecitabine was generally high in our local population. Attention should be given to non-Malay males and patients having nausea, vomiting or other side effects. Sufficient information, proactive assessment and appropriate management of side effects would improve patient satisfaction and thus create motivation to adhere to treatment plans.

#Adherence #capecitabine #oral chemotherapy #ethnicity #gender #Malaysia

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Zahrina, Abdul Kadir

소속기관 Unit of Biostatistics and Research Methodology, School of Medical Sciences, Universiti Sains Malaysi